Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503357 · ClinicalTrials.gov registry record · NA
ConsCIOUS2 Study of the Isolated Forearm Technique Commands
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 344
- Enrollment target
NCT03503357: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT03503357 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 344 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03503357, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 344 participants
- Enrollment target
Study Summary
ConsCIOUS-2 is a multi-site study exploring the cognitive state of the Isolated Forearm Test (IFT) responder while under anesthetic.
Primary Outcome
Identify the incidence of IFT responsiveness following intubation assessed by hand squeezing response following a randomized command sequence to assess for non-specific responses.
Interventions
- OTHER IFT Testing1
- OTHER IFT Testing 2
- OTHER IFT Testing 3
- OTHER IFT Testing 4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2018-04-04 |
| Est. Completion | 2019-12-23 |
| Phase | NA |
What the finished NCT03503357 record still lists
NCT03503357 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 4 interventions - of which IFT Testing1 is the first listed.
NCT03503357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03503357 about?
NCT03503357 is a clinical study titled "ConsCIOUS2 Study of the Isolated Forearm Technique Commands". ConsCIOUS-2 is a multi-site study exploring the cognitive state of the Isolated Forearm Test (IFT) responder while under anesthetic.
What is the current status of trial NCT03503357?
This trial is currently completed. It is a NA study. The enrollment target is 344 participants. The study started on 2018-04-04. Estimated completion is 2019-12-23.
What interventions are being tested in trial NCT03503357?
The interventions under investigation include: IFT Testing1 (OTHER), IFT Testing 2 (OTHER), IFT Testing 3 (OTHER), IFT Testing 4 (OTHER).
Who is sponsoring clinical trial NCT03503357?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03503357's enrollment target sits among peer trials
344 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI